Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2008 1
2009 1
2010 1
2014 2
2015 1
2016 1
2018 1
2019 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma.
Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK, Sun H, Pratt D, Sajjakulnukit P, Zhao SG, Davis M, Nelson BS, Halbrook CJ, Zhang L, Gatto F, Umemura Y, Walker AK, Kachman M, Sarkaria JN, Xiong J, Morgan MA, Rehemtualla A, Castro MG, Lowenstein P, Chandrasekaran S, Lawrence TS, Lyssiotis CA, Wahl DR. Zhou W, et al. Among authors: lowenstein p. Nat Commun. 2020 Jul 30;11(1):3811. doi: 10.1038/s41467-020-17512-x. Nat Commun. 2020. PMID: 32732914 Free PMC article.
Current state and future prospects of immunotherapy for glioma.
Kamran N, Alghamri MS, Nunez FJ, Shah D, Asad AS, Candolfi M, Altshuler D, Lowenstein PR, Castro MG. Kamran N, et al. Among authors: lowenstein pr. Immunotherapy. 2018 Feb 1;10(4):317-339. doi: 10.2217/imt-2017-0122. Immunotherapy. 2018. PMID: 29421984 Free PMC article. Review.
Overview of current immunotherapeutic strategies for glioma.
Calinescu AA, Kamran N, Baker G, Mineharu Y, Lowenstein PR, Castro MG. Calinescu AA, et al. Among authors: lowenstein pr. Immunotherapy. 2015;7(10):1073-104. doi: 10.2217/imt.15.75. Immunotherapy. 2015. PMID: 26598957 Free PMC article. Review.
Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
Sabater-Lleal M, Huffman JE, de Vries PS, Marten J, Mastrangelo MA, Song C, Pankratz N, Ward-Caviness CK, Yanek LR, Trompet S, Delgado GE, Guo X, Bartz TM, Martinez-Perez A, Germain M, de Haan HG, Ozel AB, Polasek O, Smith AV, Eicher JD, Reiner AP, Tang W, Davies NM, Stott DJ, Rotter JI, Tofler GH, Boerwinkle E, de Maat MPM, Kleber ME, Welsh P, Brody JA, Chen MH, Vaidya D, Soria JM, Suchon P, van Hylckama Vlieg A, Desch KC, Kolcic I, Joshi PK, Launer LJ, Harris TB, Campbell H, Rudan I, Becker DM, Li JZ, Rivadeneira F, Uitterlinden AG, Hofman A, Franco OH, Cushman M, Psaty BM, Morange PE, McKnight B, Chong MR, Fernandez-Cadenas I, Rosand J, Lindgren A; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium (ISGC); Gudnason V, Wilson JF, Hayward C, Ginsburg D, Fornage M, Rosendaal FR, Souto JC, Becker LC, Jenny NS, März W, Jukema JW, Dehghan A, Trégouët DA, Morrison AC, Johnson AD, O'Donnell CJ, Strachan DP, Lowenstein CJ, Smith NL. Sabater-Lleal M, et al. Among authors: lowenstein cj. Circulation. 2019 Jan 29;139(5):620-635. doi: 10.1161/CIRCULATIONAHA.118.034532. Circulation. 2019. PMID: 30586737 Free PMC article.
Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial.
Löwenstein O, Leyendecker P, Hopp M, Schutter U, Rogers PD, Uhl R, Bond S, Kremers W, Nichols T, Krain B, Reimer K. Löwenstein O, et al. Expert Opin Pharmacother. 2009 Mar;10(4):531-43. doi: 10.1517/14656560902796798. Expert Opin Pharmacother. 2009. PMID: 19243306 Clinical Trial.
METHODS: During pre-randomisation patients receiving opioids for moderate-to-severe non-malignant pain were converted to oxycodone PR (OXY PR) and titrated to an effective analgesic dose. During randomisation 265 patients on a stable OXY PR dose (60-80 mg/day …
METHODS: During pre-randomisation patients receiving opioids for moderate-to-severe non-malignant pain were converted to oxycodone PR …
Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials.
Löwenstein O, Leyendecker P, Lux EA, Blagden M, Simpson KH, Hopp M, Bosse B, Reimer K. Löwenstein O, et al. BMC Clin Pharmacol. 2010 Sep 29;10:12. doi: 10.1186/1472-6904-10-12. BMC Clin Pharmacol. 2010. PMID: 20920236 Free PMC article. Clinical Trial.
METHODS: These studies were prospectively designed to be pooled and the primary outcome measure of the pooled data analysis was to demonstrate non-inferiority in 12-week analgesic efficacy of oxycodone PR/naloxone PR versus oxycodone PR alone. Patients with o …
METHODS: These studies were prospectively designed to be pooled and the primary outcome measure of the pooled data analysis was to demonstra …
Determinants of Childhood Zoonotic Enteric Infections in a Semirural Community of Quito, Ecuador.
Lowenstein C, Vasco K, Sarzosa S, Salinas L, Torres A, Perry MJ, Simmens SJ, Trueba G, Eisenberg JNS, Graham JP. Lowenstein C, et al. Am J Trop Med Hyg. 2020 Jun;102(6):1269-1278. doi: 10.4269/ajtmh.19-0690. Am J Trop Med Hyg. 2020. PMID: 32228797 Free PMC article.
Children who interacted with domestic animals-a behavior reported by nearly three-quarters of households owning animals-were at an increased risk of colonization with at least one zoonotic enteric pathogen (prevalence ratio [PR] = 1.56, 95% CI: 1.00-2.42). The risk of diar …
Children who interacted with domestic animals-a behavior reported by nearly three-quarters of households owning animals-were at an increased …
Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.
Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K. Simpson K, et al. Among authors: lowenstein o. Curr Med Res Opin. 2008 Dec;24(12):3503-12. doi: 10.1185/03007990802584454. Curr Med Res Opin. 2008. PMID: 19032132 Clinical Trial.
This Phase III clinical trial assessed the safety and efficacy of an oral fixed-ratio combination of oxycodone prolonged-release (PR) and naloxone PR compared with oxycodone PR in relieving opioid-induced constipation. ...Following a run-in phase patients wer …
This Phase III clinical trial assessed the safety and efficacy of an oral fixed-ratio combination of oxycodone prolonged-release (PR) …
Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study.
Hesselbarth S, Löwenstein O, Cegla T. Hesselbarth S, et al. Among authors: lowenstein o. Scand J Pain. 2014 Apr 1;5(2):75-81. doi: 10.1016/j.sjpain.2014.01.004. Scand J Pain. 2014. PMID: 29913668 Free article.
Controlled clinical trials comparing PR oxycodone/naloxone with strong opioids other than oxycodone are not available. ...Implications The present findings underline the value of PR oxycodone/naloxone in the management of patients with moderate to severe chronic pai …
Controlled clinical trials comparing PR oxycodone/naloxone with strong opioids other than oxycodone are not available. ...Implication …
Second-degree atrioventricular block: Mobitz type II.
Wogan JM, Lowenstein SR, Gordon GS. Wogan JM, et al. Among authors: lowenstein sr. J Emerg Med. 1993 Jan-Feb;11(1):47-54. doi: 10.1016/0736-4679(93)90009-v. J Emerg Med. 1993. PMID: 8445186
Mobitz type II second-degree block is an old term, which refers to periodic atrioventricular block with constant PR intervals in the conducted beats. The distinction between type II and type I block is descriptive; of greater importance to the clinician is the anatomic sit …
Mobitz type II second-degree block is an old term, which refers to periodic atrioventricular block with constant PR intervals in the …
12 results